Noninvasive PET quantitative myocardial blood flow with regadenoson for assessing cardiac allograft vasculopathy in orthotopic heart transplantation patients.

@article{Pampaloni2017NoninvasivePQ,
  title={Noninvasive PET quantitative myocardial blood flow with regadenoson for assessing cardiac allograft vasculopathy in orthotopic heart transplantation patients.},
  author={Miguel Hernandez Pampaloni and Uttam M Shrestha and Maria Sciammarella and Youngho Seo and Grant T. Gullberg and Elias H. Botvinick},
  journal={Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology},
  year={2017},
  volume={24 4},
  pages={
          1134-1144
        }
}
BACKGROUND Risk stratification and early detection of cardiac allograft vasculopathy (CAV) is essential in orthotopic heart transplantation (OHT) patients. This study assesses the changes in myocardial blood flow (MBF) noninvasively in OHT patients using quantitative cardiac PET with regadenoson. METHODS Twelve patients (Group 1) (8 males, 4 females, mean age 55 ± 7 years) with no history of post OHT myocardial ischemia were enrolled 5.4 ± 2.0 years after OHT. Fifteen patients (Group 2) (9… CONTINUE READING
2 Citations
33 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 33 references

Similar Papers

Loading similar papers…